Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 280

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers

Open access
Co-Chairmen of the Task Force:, Boe, J., Dennis, J.H., O'Driscoll, B.R., Members of Task Force:, Bauer, T.T., Carone, M., Dautzenberg, B., Diot, P., Heslop, K., Lannefors, L. · 2001 · European Respiratory Journal

Abstract

The European Respiratory Society (ERS) recognizes that there are an increasing number of national and international guidelines for the management of asthma, chronic obstructive pulmonary disease (COPD) and other chest diseases. Some of these guidelines recommend nebulizer use in specific circumstances, using either a jet nebulizer or an ultrasonic nebulizer to administer a drug to the airways or lungs in the form of an aerosolized mist of fine droplets. Although many patients with severe chest disease are given nebulized treatment both in hospitals and in their own homes, it is recognized that much of this practice may not be evidence-based. Some present practice may be ineffective or even harmful. The manufacturers of hand-held inhalers are obliged to meet exacting standards such as dose-to-dose reproducibility. However, nebulizer devices are sold separately from nebulized drugs and the dose delivered to the lung can be increased 10-fold or more by changing from an inefficient nebulizer system to a highly efficient one. For these reasons, the ERS commissioned a Task Force to review the scientific and clinical principles of nebulized therapy and to produce a set of guidelines (evidence-based whenever possible) for users of nebulized treatment in Europe. It is hoped that the guidelines will improve clinical practice in the use of nebulized therapy throughout Europe. The most important considerations should be efficacy and patient safety. The guidelines will also serve as an educational and scientific resource for clinicians and scientists with an interest in inhaled therapy. These guidelines are aimed at a wide group of healthcare professionals practising in very different healthcare systems throughout Europe. The immediate target audience for the guidelines will be pulmonary physicians, but it is hoped that the messages will be communicated to all healthcare workers who are involved in treating patients with nebulized medication (doctors, nurses, pharmacists, paramedics, …

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.01.00220001

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 280

Metadata

Authors
Co-Chairmen of the Task Force:, Boe, J., Dennis, J. H., O'Driscoll, B. R., Members of Task Force:, Bauer, T. T., Carone, M., Dautzenberg, B., Diot, P., Heslop, K., & Lannefors, L.
Venue
European Respiratory Journal
Published
2001-07
Volume
18
Issue
1
Pages
228-242
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2135298892
Cited by
280
References
2
FWCI
4.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers. https://app.cochat.ai/papers/10.1183/09031936.01.00220001
The paper
Co-Chairmen of the Task Force:, Boe, J., Dennis, J. H., O'Driscoll, B. R., Members of Task Force:, Bauer, T. T., Carone, M., Dautzenberg, B., Diot, P., Heslop, K., & Lannefors, L. (2001). European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers. European Respiratory Journal. https://doi.org/10.1183/09031936.01.00220001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.